ACTICOAT^◊ 7 with SILCRYST^TM is an effective antimicrobial barrier dressing. The Nanocrystalline^† coating of silver rapidly kills a broad spectrum of bacteria in as little as 30mins and is effective for up to 7 days. ACTICOAT^◊ 7 consists of five layers: two layers of an absorbent inner core sandwiched between three layers of silver coated, low adherent polyethylene net. Nanocrystalline^† silver protects the wound site from bacterial contamination while the inner core helps maintain the moist environment optimal for wound healing.

Nanocrystalline^† Silver Antimicrobial barrier
ACTICOAT^◊ 7 dressing provides unique protection for the wound site.

Effective barrier to bacterial penetration
ACTICOAT^◊ 7 provides an effective barrier to protect the wound site from invasive pathogens.

Broad spectrum antimicrobial activity
(In-vitro data shows) ACTICOAT^◊ 7 is effective in vitro against to over 150 pathogens which includes a broad spectrum of gram positive and negative bacteria and fungal wound pathogens.

ACTICOAT^◊ 7 is also effective in vitro against Antibiotic resistant Pseudomonas, Methicillin resistant Staphylococcus aureus (MRSA) and Vancomycin resistant Enterococcus (VRE).

Fast acting
In vitro data shows ACTICOAT^◊ 7 rapidly kills bacteria in as little as 30 minutes.

Prevents and reduces infection
ACTICOAT^◊ 7 kills pathogenic organisms in wounds to reduce the risk of infection.  
ACTICOAT^◊ 7 is also effective in the reduction of bacterial load in wound.

Assists faster healing
ACTICOAT^◊ 7 contributes to effective wound bed preparation and helps maintain a moist wound environment to assist faster healing.

Sustained release of silver for 7 days
The sustained release of silver ensures that ACTICOAT^◊ 7 remains effective for up to 7 days.

Easy to use
Easy to apply and remove.  Can be cut to shape.

Low toxicity
Unlike some antimicrobial agents, the silver in ACTICOAT^◊ 7 does not inhibit wound healing.

Low adherent
Dressing changes are less traumatic than traditional methods for both the patient and the carer. 

ACTICOAT^◊ 7 Indicated as an antimicrobial barrier layer over partial and full thickness wounds such as pressure ulcers, leg ulcers, diabetic foot ulcers, burns, and recipient graft sites.

Contraindications:

• Do not use on a patient undergoing MRI (Magnetic Resonance Imaging) examination 
• Do not use on patients with a known sensitivity to silver 
• Prior to administering radiation therapy, remove ACTICOAT^◊ 7. A new dressing can be applied following treatment.

Precautions: 

• For external use only 
• ACTICOAT^◊ 7 is not compatible with oil-based products, such as petrolatum 
• Avoid contact with electrodes or conductive gels during electronic measurements e.g. EEG and ECG 
• ACTICOAT^◊ 7 may cause transient discolouration of the surrounding skin 
• Do not use if product colour is not uniform

Catalogue#	Size	Carton Qty
66000796	10cm x 12.5cm	5
66000797	15cm x 15cm	5

^†Nanocrystalline Silver is a patented technology of NUCRYST Pharmaceuticals Corp.
^TM SILCRYST is a trademark of NUCRYST Pharaceuticals Corp, used under licence